AI assistant
Inogen Inc — Director's Dealing 2022
Sep 7, 2022
33625_dirs_2022-09-06_eca5e6d3-c521-41dd-a57b-6b8e6897a6c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2022-09-01
Reporting Person: Glezer Stanislav (EVP, Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-01 | Common Stock | M | 3075 | $0.00 | Acquired | 3075 | Direct |
| 2022-09-01 | Common Stock | S | 1576 | $28.16 | Disposed | 1499 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-01 | Restricted Stock Unit | $ | M | 3075 | Disposed | Common Stock (3075) | Direct |
Footnotes
F1: The reported shares were sold to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2022.
F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F3: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.